Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.18 Til Enterprise Value: 1.58 Til PE Ratio: 36.22 PB Ratio: 20.20 GF Score: 92/100

Amgen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 06:45PM GMT
Release Date Price: HK$1850
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley, and very pleased to have Amgen with us for the next session.

Before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/research disclosures.

And with that, very pleased to have Bob Bradway, the CEO of Amgen, with us. And Bob, I'm going to turn it over to you to make some opening comments, and then we'll jump into the Q&A.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Okay, Matt. Well, thanks for having us. I look forward to the day where we can actually be back together in the same conference room. But in the meanwhile, maybe I could just open with a few comments and then turn it over to you for questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot